were used when 1 brachial pressure was higher than the opposite brachial pressure in both measurement sets and the 2 brachial pressures differed by 10 mmHg or more in at least 1 measurement set because, in such cases, subclavian stenosis was possible. 20 The lowest leg ABI was used in analyses.
Carotid artery intima-media thickness The evaluation of carotid intima-media thickness (IMT) were assessed using high-resolution B-mode 3-9 MHz linear transducer (IE 33 ultrasound system, Philips Medical Systems, Andover, Massachusetts, United States) as previously described. Briefly bilateral measurements were made at the posterior wall of the bulb of the common carotid artery and at the internal carotid artery through a program of automatic edge detection (QLAB version 7.1 software, Philips Medical Systems, Andover, Massachusetts, United States). 21 The highest IMT was used for analysis.
Computed tomography coronary angiography acquisition CTCA was performed using dual source computed tomogragphy (DSCT) (Somatom Definition, Siemens Medical Solutions, Erlangen, Germany). In patients with a heart rate above 70/min and no contraindication to β-blocker, 25 to 100 mg of metoprolol was given orally 1 hour before CTCA examinations to achieve heart rate below 70/min. In cases of insufficient heart rate reduction or the presence of contraindications to β-blockade, CTCA was performed at heart rates higher than 70/min. Patients were premedicated with sublingual nitrates directly before CTCA acquisition.
A noncontrast axial scan was performed craniocaudally (3-mm section thickness without gap) at 70% of R-R interval with prospective ECG triggering to obtain coronary artery calcium score (CACS). Subsequently, the arrival time of contrast agent to the ascending aorta was determined at the level of the carina with the use of the test bolus method (20 ml of iopromid 370 contrast followed by a 20 ml saline chaser). Iopromid 370 contrast (1.2 ml/kg) was injected at a rate of 5.5 ml/s followed by a 40 ml saline chaser at similar rates. Retrospective ECG-gated image acquisition was performed during inspiratory breath hold. The imaging parameters were: 2 × 64 × 0.6 mm collimation, 330 ms rotation time, table feed of 9.2 mm per rotation, tube voltage 120 kV, an effective tube current of 300 to 400 mA and a temporal resolution of 165 ms. Electrocardiographically controlled tube current modulation was applied in all patients. Tube voltage was reduced to 100kV, when patient's body mass index was less than 25 kg/m 2 . The effective radiation dose estimate was 10.1 ±2.8 mSv.
Images were reconstructed using a B26f kernel with an image matrix of 512 × 512 pixels. A DSCT scanner utilized a slice thickness of 0.75 mm and an increment of 0.5 mm with an ECG-gated half-scan algorithm. A multiphase reconstruction invasive coronary angiography, which showed that even >70% of subjects with PAD may have CAD. 7 Recently, computed tomography coronary angiography (CTCA) has emerged as a new imaging modality, which enables noninvasive evaluation of coronary artery atherosclerosis. 8 Currently, the European Society of Cardiology guidelines on the management of coronary artery disease has clarified the role of CTCA to detect CAD in subjects with low intermediate pretest probability of the disease. 9 Moreover, prior studies have demonstrated that the extent and severity of CAD as well as the composition of coronary artery plaques determined by CTCA are related to clinical outcomes and may be used to stratify cardiovascular risk. [10] [11] [12] [13] [14] Nevertheless, the value of CTCA to assess coronary artery atherosclerosis in subjects with lower extremity PAD and no cardiac symptoms has not been evaluated. Importantly, ESC guidelines on the diagnosis and treatment of peripheral artery diseases only raise the question of whether such identification of CAD would improve clinical outcomes. 15 Of note, no data exist to assess the relationship between coronary artery plaque characteristics and severity of peripheral atherosclerosis. Therefore, the aim of the study was to determine the value of CTCA to assess the presence and extent of CAD and to evaluate the relationship between coronary artery plaque characteristics and severity of peripheral atherosclerosis in subjects with lower extremity PAD and no cardiac symptoms.
PATIENTs ANd mEThOds study population Sixty--five patients with intermittent claudication due to PAD and no cardiac symptoms were enrolled to the study. The exclusion criteria included age <50 years, known coronary artery disease, impaired left ventricular systolic function, irregular heart rate, significant valvular heart disease, prior peripheral artery intervention and/or surgery, prior stroke, respiratory failure, obesity, pregnancy, known iodinated contrast allergy, impaired renal function (serum creatinine ≥1.5 mg/dl) and thyroid disorders. All patients underwent carotid ultrasound evaluation, CTCA and estimation of the ankle-brachial index (ABI). This study was approved by the local ethics committee and informed consent was obtained from each patient.
Ankle-brachial index A hand-held Doppler probe (Hadeco Bidop ES-100V3, Hadeco Inc, Arima, Japan) was used by qualified sonographer blinded to clinical, carotid ultrasound, and CTCA data to obtain systolic pressures in the right and left brachial, dorsalis pedis, and posterior tibial arteries, as previously described.
16-19 Briefly, ABI was calculated by dividing the mean of the dorsalis pedis and posterior tibial pressures in each leg by the mean of the 4 brachial pressures.
20 Each pressure was measured twice. Zero values for the dorsalis pedis and posterior tibial pulses were set to missing for the ABI calculation. Average brachial pressures in the arm with highest pressure were considered statistically significant at a P value of <0.05. Statistical analyses were performed using the SPSS software (version 12.0, SPSS Inc., Chicago, Illinois, United States).
REsuLTs baseline characteristics A total of 65 subjects (45 men, 20 women, mean age, 62.5 ±7.6 years) with lower extremity PAD formed the study group. All subjects denied typical/atypical cardiac chest pain. According to the Fontaine classification, 38 subjects were in stage IIa and 27 subjects in stage IIb. The reported maximal walking distance till claudication was 318 ±324 m. All subjects demonstrated a decreased ABI of <0.9 and 26 had increased carotid artery IMT. Thirty-three individuals reported current smoking, 25 prior smoking, 43 hypertension, 45 hypercholesterolemia, and 15 diabetes mellitus. Forty-four subjects were on aspirin, 4 on clopidogrel, 2 on ticlopidine, 15 on β-blockers, 19 on angiotensin-converting enzyme inhibitor, 8 on angiotensin receptor blocker, 22 on calcium antagonists, 16 on diuretics, and 1 on spironolactone. Forty subjects were on statins and 1 on fibrates. The clinical characteristics of the patients is shown in TAbLE 1. The mean ABI was 0.64 ±0.16 with the median value of 0.63. Thirty-nine subjects had normal IMT bilaterally, whereas 26 demonstrated abnormal IMT on at least 1 side. Comparing subjects with ABI <me-dian and ABI ≥median, no difference in age, sex, and cardiovascular risk factors prevalence was found (all P = nonsignificant [NS]). Subjects with abnormal IMT were older than those with normal IMT (65.2 ±8.3 vs. 61.2 ±6.4 years, P = 0.009). The prevalence of sex and cardiovascular risk factors in subjects with normal and abnormal IMT did not differ significantly (all P = NS).
Computed tomography coronary angiography feasibility The mean heart rate at scan time was 65 ±8 beats/min. Of a total of 1040 evaluated coronary segments, 165 segments were excluded due to a diameter <1.5 mm. Of the remaining 875 segments, 32 were considered uninterpretable. Segments were uninterpretable for the following reasons: a) severe calcifications: 18 segments, b) motion artifacts: 9 segments, c) image noise or poor opacification: 3 segments and stair step artifacts in 2 segments.
Computed tomography coronary angiography findings Normal coronary arteries were found in 9 patients. Of the remaining 56 patients, 22 had obstructive CAD and 34 nonobstructive CAD. Single-vessel CAD was present in 13 and multivessel CAD in 43 patients. Obstructive single-vessel CAD was found in 13 and obstructive multivessel CAD in 9 patients. Two subjects had obstructive left main coronary artery stenosis. Noncalcified, mixed, and calcified plaques were present in 73, 111, and 51 coronary artery segments, respectively. CTCA characteristics with respect to ABI and IMT values are shown in 
Computed tomography coronary angiography analysis ll CTCA examinations were evaluated by experienced readers who were blinded to the clinical data, ABI, and IMT measurements. Coronary artery calcium was defined as a plaque of at least 3 contiguous pixels with attenuation of 130 HU or greater. 22 The CACS was calculated according to the Agatston method. 23 The total CACS was calculated from the sum of each of the 4 major epicardial vessels (left main, left anterior descending, circumflex, and right coronary arteries).
A modified American Heart Association 16-segment model of the coronary arteries was employed and segments with a diameter of ≤1.5 mm were excluded from the analysis. 24 The remaining segments were determined to be interpretable or uninterpretable, and interpretable segments were assessed for the presence and location of atherosclerotic plaques using axial and curved multiplanar reconstructions. Coronary plaques were defined as >1mm 2 area structures within and/or adjacent to the coronary artery lumen with clear, well-defined borders. 10 By comparing the plaque and contrast-enhanced vessel lumen density, 3 different types of plaques were reported. Plaques with higher density than the contrast enhanced lumen were defined as calcified, while those with lower density were labeled as noncalcified. Plaques with both calcified and noncalcified elements were considered mixed plaques. 10 When ≥2 plaques of the same composition were present in a single coronary segment, only 1 plaque having that composition was assigned to that particular segment. The degree of luminal narrowing was compared to the nearest normal-appearing segment and plaques were classified as obstructive (≥50% luminal narrowing) or nonobstructive (<50% luminal narrowing). Coronary arteries were considered abnormal if plaque was present and normal if no plaque was identified. Patients with ≥1 obstructive plaque were considered to have obstructive CAD while those with only nonobstructive plaque(s) were labeled as having nonobstructive CAD.
10,14
statistical analysis Continuous data are presented as a mean ± standard deviation and categorical data as prevalence (%). The normal distribution was verified using the Kolmogorov-Smirnov test. Unpaired categorical variables were compared by Fisher exact or χ 2 tests depending on the sample size. Student's t test was used to assess differences between continuous variables. Spearman rank correlation was performed to assess the relationship between number of coronary artery segments with obstructive luminal narrowing and indexes of peripheral atherosclerosis. Differences of multivessel to single-vessel coronary artery plaque extent (21:1 vs. 22:12, P = 0.01), higher proportion of obstructive multivessel to single vessel CAD (7:3 vs. 2:10, P = 0.01), and higher number of coronary artery segments with any plaques (4.9 ±4.3 vs. 2.8 ±2.6, P = 0.02), noncalcified plaques (1.9 ±3.2 vs. 0.6 ±1.4, P = 0.04), and mixed plaques (2.3 ±2.1 vs. 1.3 ±1.7, P = 0.049). The number of coronary artery segments with obstructive luminal narrowing tended to correlate with ABI (r = -0.22, P = 0.09) and IMT (r = 0.24, P = 0.05).
dIsCussION The major finding of the study is that CTCA may be regarded as an effective diagnostic tool to depict CAD in subjects with lower CACS values and CAD prevalence were found between subjects with ABI < median and ABI ≥ median as well as between subjects with normal and abnormal IMT. Comparing subjects with ABI < median and ABI ≥ median, the former demonstrated higher proportion of multivessel to single-vessel coronary artery plaque extent (24:2 vs. 19:11, P = 0.01), higher proportion of obstructive multivessel to single-vessel CAD (8:4 vs. 1:9, P = 0.01) and higher number of coronary artery segments with mixed plaques (2.3 ±2.2 vs. 1.2 ±1.3, P = 0.02). The number of coronary artery segments with noncalcified and calcified plaques did not differ between both groups. Subjects with abnormal IMT, when compared with those with normal IMT, demonstrated higher proportion Data are presented as mean ± standard deviation or number (percentage).
a The lowest values were taken for analysis.
Abbreviations: ABI -ankle-brachial index, BMI -body mass index, GFR -glomerular filtration rate, HDL -high-density lipoprotein cholesterol, IMT -intima-media thickness, LDL-C -low-density lipoprotein cholesterol, TC -total cholesterol, TG -triglycerides which are known markers of polyvascular atherosclerosis. 29, 30 In consequence, the presence of low ABI or abnormal IMT might be used as indicators of coronary artery involvement in subjects with PAD and no cardiac symptoms. Prior studies have shown that both IMT and ABI are strong predictors of cardiovascular events including death and myocardial infarction. 28,32-37 Interestingly, we observed an association between lower ABI and higher number of mixed coronary artery plaques as well as abnormal IMT and higher number of noncalcified and mixed coronary artery plaques. These associations might reflect differences in atherosclerotic process in studied subgroups and might explain the link between higher number of cardiovascular events and abnormal ABI and IMT. In fact, noncalcified and mixed plaques represent atherosclerotic lesions that are more prone to rupture than calcified plaques. 38,39 Numerous studies have shown that the number of coronary artery segments with noncalcified and mixed plaques improves prognostication of adverse cardiovascular events and provides incremental value over clinical and myocardial perfusion data to stratify cardiovascular risk. [10] [11] [12] [13] [14] There are several limitations of the study that should be acknowledged. First, the number of studied patients was small. Second, due to limitation in spatial resolution of CCTA, we have excluded coronary artery segments with a diameter of ≤1.5 mm. Consequently, we might have underestimated the extent and severity of coronary artery plaque burden. Finally, we have not performed invasive coronary angiography to assess the diagnostic value of CCTA. However, the diagnostic value of CCTA has been widely evaluated and our study was not planned to assess the issue.
8 extremity PAD and no cardiac symptoms. The extent of coronary artery atherosclerosis and number of disease vessels is related to the severity of lower-limb ischemia and IMT. Importantly, subjects with lower ABI and abnormal IMT demonstrated a higher burden of high-risk coronary artery plaques, which are known to be associated with higher incidence of adverse cardiac events.
To date, numerous studies have demonstrated high prevalence of CAD in subjects with lower extremity PAD. 2, 4, 5, 7, 25 The findings of the current study correspond to prior observations and show that obstructive CAD is frequent in subjects with PAD and no cardiac symptoms. 2, [4] [5] [6] Interestingly, we have found the presence of obstructive CAD in one-third of the enrolled subjects with high percentage of multivessel obstructive CAD. Owing to intermittent claudication, noninvasive detection of obstructive CAD in patients with PAD is a diagnostic challenge during exertional stress. In consequence, most studies utilized pharmacological stress during echocardiography or SPECT to detect myocardial ischemia.
5,26 The current study shows that CTCA may be used as an alternative to detect obstructive CAD in this group of patients. Nevertheless, the technique has some limitations including lower spatial and temporal resolution as compared with invasive coronary angiography, the lack of information on functional significance of stenotic lesions, exposure to radiation and iodinated contrast agent, and difficulty to assess severely calcified coronary artery lesions, which may be frequent in subjects with PAD. 8, 27 Atherosclerosis is a polyvascular disease and the presence of atherosclerosis on the vascular bed increases its risk in another vascular location. 1, [28] [29] [30] [31] The current data support these observations and demonstrate that the extent of obstructive CAD is related to ABI and IMT values, Data are presented as mean ± standard deviation or number (percentage).
Abbreviations: CACS -coronary artery calcium score, CAD -coronary artery disease, MVD -multivessel disease, SVD -single-vessel disease, others -see TAbLE 1 Concluding, CCTA may be an effective diagnostic tool to detect CAD in subjects with PAD and no cardiac symptoms. The low ABI and abnormal IMT are associated with more extensive CAD and higher burden of high-risk coronary artery plaques, suggesting potential explanation of the link between increased cardiovascular risk and abnormal ABI and IMT values.
